Loading...

PAR Par Drugs & Chemicals Ltd Investor Conferences Announcement

Pr D

PR

Par Drugs & Chemicals Ltd

(PAR)

2024 Announcement

Ex-Parte Interim Order

Newspaper publication

Unaudited Results

Board meeting outcomes

Unaudited Standalone Results

Unaudited Standalone Results

Saksham Niveshak Campaign

Regulatory Action

SEBI Certificate Issued

Trading Window Closure

Director Re-Appointed

Director Re-Appointment

Auditor Re-Appointment

AGM Report Submitted

AGM Proceedings

Annual General Meeting

SEBI Interim Order

Annual Report Notification

AGM Notice Publication

Board Meeting Outcome

Auditor Appointment

Record Date Announcement

Annual General Meeting

Board Meeting Outcome

Board Meeting Outcome

Newspaper Publication

Board Meeting Outcome

Board Meeting Results

Board Meeting Outcome

Financial Results Report

SEBI Compliance Certificate

Trading Window Closure

SEBI Meeting Update

SEBI Meeting Notification

Financial Results Published

Board Meeting Outcome

Board Meeting Outcome

Board Meeting Outcome

Board Meeting Outcome

GST Audit Report

Compliance Certificate

Disclosure Submission

Certificate Submission

Business Unit Sale

Trading Window Closure

Financial Results Publication

Slump Sale Agreement

Slump Sale Agreement

Board Meeting Outcome

Board Meeting Outcome

Q4 Earnings Report

Board Meeting Outcome

Financial Results Released

Voting Results EGM

EGM Scrutinizer Report

EGM Proceedings

New Business Line

EGM Proceedings 2025

Newspaper Publication

GST Order Update

Record Date Announced

Extraordinary General Meeting

EGM Announcement

Board Meeting Update

Business Expansion Plans

Board Meeting Held

SEBI Certificate Issued

Director Cessation

EGM Scrutinizer Report

Extraordinary Meeting

EGM Proceedings

Trading Window Closure

EGM Notice Published

EGM Record Date

Extraordinary General Meeting

EGM Announcement

Board Meeting Outcome

Trading Window Closure

GST Regulatory Update

Financial Results

Board Meeting Outcome

Financial Results Meeting

Financial Results Approval

Financial Results

Regulatory Compliance

Trading Window Closure

AGM Voting Results

AGM Voting Results

25th AGM Proceedings

Annual General Meeting

AGM Notice Published

Regulatory Notice

GST Notice Received

Book Closure Notice

Annual General Meeting

Board Meeting Outcome

Annual General Meeting

Board Meeting Outcome

Board Meeting Outcomes

Newspaper Publication

Board Meeting Outcome

Board Meeting Outcomes

Financial Results Approval

Financial Results Submission

Certificate Submission

Trading Window Closure

Income Tax Notice

GST Audit Notice

Quarterly Earnings

Outcome of Board Meeting

Board Meeting Outcomes

Financial Reports Approval

Financial Results Submission

Disclosure of shares declar...

CSR Project Launch

Certificate Submission

Drop Proceeding Order

Trading Window Closure

Non-compliance Notice

Board Meeting Outcome

Board Meeting Outcomes

Board Meeting Outcomes

Income Tax Verification

Financial Results

Financial Results Approval

Board Meeting Outcomes

Board Meeting Outcome

Financial Results Submission

Board Meeting Rescheduled

Certificate Submission

Notice from GST Authority

GST Show Cause Notices

GST Show Cause Notices

Trading Window Closure

Related Party Transactions ...

Certificate under SEBI (Dep...

Trading Window Closure

Register Closure

Financial Results for Q2 2023

Financial Results

Financial Results

Board Meeting Outcome

Financial Results Approval

Board Meeting Outcome

Financial Results Submission

Financial Results

External Links:

Data:

Par Drugs and Chemicals Limited will hold its 25th Annual General Meeting on September 21, 2024, at 11:00 AM at Hotel Tara Suns, Vadodara, with e-voting starting from September 17 to September 20, 2024. The meeting will cover various approvals including re-appointments and the purchase of land for a new R&D lab costing approximately Rs 12 crore.

AI Assistant

Par Drugs & Chemicals Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.